Steven R. Schow
Overview
Steven R. Schow received an average of $284K in total compensation, including $243K in salary, at MabVax Therapeutics Holdings from 2010 to 2012.
Source: SEC filings on April 5, 2013 and March 5, 2012.
Related executives
We found 11 more executives who work or worked at MabVax Therapeutics Holdings.
J Hansen
MabVax Therapeutics Holdings
Chief Executive Officer
Paul Resnick
MabVax Therapeutics Holdings
Vice President, Chief Business Officer
Paul Maffuid
MabVax Therapeutics Holdings
Vice President, Pharmaceutical Development and Operations
Gregory Hanson
MabVax Therapeutics Holdings
Chief Financial Officer
Wolfgang Scholz
MabVax Therapeutics Holdings
Vice President, Antibody Discovery
Michael Wick
MabVax Therapeutics Holdings
Chief Executive Officer
William Kaplan
MabVax Therapeutics Holdings
General Counsel
Wendy Wee
MabVax Therapeutics Holdings